European Institute of Oncology Reggio Calabria , Italy; Baskent University Hospital, Haematology Division Adana, Turkey; CHU Nantes, Department D'Hematologie King Faisal Specialist Hospital & Research Centre, Oncology (Section of Adult Haematolgy/BMT), Riyadh, Saudi Arabia; University of Cologne, I. Department of Medicine, Cologne, Germany; Ospedale San Gerardo, Clinica Ematologica dell'Universita Milano-Biocca Klinkum Rechts der Isar, III Med Klinik der TU, Munich, Germany; University of Napoli, 'Federico II' Medical School, Division of Hematology Hopital Saint Antoine, Department of Hematology Adult and Paediatric Transplant Centre Belgium; Specialized Children's Oncohematology Hospital, Citta della Salute e della Scienza di Torino Klinik und Poliklinik II ,
Cancer statistics, 2016, CA: A Cancer Journal for Clinicians, vol.61, issue.suppl 3, pp.7-30, 2016. ,
DOI : 10.1111/obr.12321
Acute lymphoblastic leukaemia, The Lancet, vol.381, issue.9881, pp.1943-55, 2013. ,
DOI : 10.1016/S0140-6736(12)62187-4
New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia, Cancer, vol.124, issue.1, pp.2517-2545, 2015. ,
DOI : 10.1002/cncr.29383
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial, British Journal of Haematology, vol.93, issue.4, pp.463-71, 2012. ,
DOI : 10.1111/j.1365-2141.2012.09095.x
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia, Cancer, vol.97, issue.12, pp.2788-801, 2004. ,
DOI : 10.1002/cncr.20668
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation, Blood, vol.120, issue.10, pp.2032-2073, 2012. ,
DOI : 10.1182/blood-2011-12-399287
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993), Blood, vol.111, issue.4, pp.1827-1860, 2008. ,
DOI : 10.1182/blood-2007-10-116582
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial, Journal of Clinical Oncology, vol.22, issue.20, pp.4075-86, 2004. ,
DOI : 10.1200/JCO.2004.10.050
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015, Bone Marrow Transplantation, vol.2012, issue.8, pp.1037-56, 2015. ,
DOI : 10.1038/bmt.2015.6
Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis, Blood, vol.121, issue.2, pp.339-50, 2013. ,
DOI : 10.1182/blood-2012-07-445098
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186648
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Update of the 2006 Evidence-Based Review, Biology of Blood and Marrow Transplantation, vol.18, issue.1, pp.18-36, 2012. ,
DOI : 10.1016/j.bbmt.2011.07.019
Acute lymphoblastic leukemia in first complete remission: temporal trend of outcomes in studies comparing allogeneic transplant with autologous transplant or chemotherapy, Annals of Hematology, vol.123, issue.6, pp.1221-1229, 2013. ,
DOI : 10.1007/s00277-013-1766-5
?No donor?? Consider a haploidentical transplant, Blood Reviews, vol.29, issue.2, pp.63-70, 2015. ,
DOI : 10.1016/j.blre.2014.09.009
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379127
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation, Bone Marrow Transplantation, vol.90, issue.7, pp.887-94, 2014. ,
DOI : 10.1182/blood-2012-06-379040
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants, Bone Marrow Transplantation, vol.8, issue.4, pp.476-82, 2015. ,
DOI : 10.1016/j.bbmt.2014.05.015
Modern approaches to HLA-haploidentical blood or marrow transplantation, Nature Reviews Clinical Oncology, vol.5, issue.1, pp.10-24, 2016. ,
DOI : 10.1182/blood-2007-03-082933
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695979
Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation, Seminars in Oncology, vol.39, issue.6, pp.683-93, 2012. ,
DOI : 10.1053/j.seminoncol.2012.09.005
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808078
Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning, Biology of Blood and Marrow Transplantation, vol.19, issue.1, pp.117-139, 2013. ,
DOI : 10.1016/j.bbmt.2012.08.014
URL : http://doi.org/10.1016/j.bbmt.2012.08.014
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies, Blood, vol.121, issue.5, pp.849-57, 2013. ,
DOI : 10.1182/blood-2012-08-453399
Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study, Clinical Cancer Research, vol.22, issue.14, pp.3467-76, 2016. ,
DOI : 10.1158/1078-0432.CCR-15-2335
Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience, Seminars in Hematology, vol.53, issue.2, pp.82-91, 2016. ,
DOI : 10.1053/j.seminhematol.2016.01.004
Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT, Haematologica, vol.101, issue.6, pp.773-80, 2016. ,
DOI : 10.3324/haematol.2015.138180
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia, Leukemia, vol.15, issue.5, pp.1069-75, 2015. ,
DOI : 10.1182/blood-2011-03-344853
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia, Journal of Hematology & Oncology, vol.33, issue.9, p.24, 2017. ,
DOI : 10.1186/s13045-017-0394-2
URL : https://hal.archives-ouvertes.fr/hal-01501594
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia, Leukemia, vol.90, issue.9, pp.1891-900, 2015. ,
DOI : 10.1182/blood-2008-02-140095
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia, Biology of Blood and Marrow Transplantation, vol.23, issue.2, pp.318-342, 2017. ,
DOI : 10.1016/j.bbmt.2016.11.008
Defining the Intensity of Conditioning Regimens: Working Definitions, Biology of Blood and Marrow Transplantation, vol.15, issue.12, pp.1628-1661, 2009. ,
DOI : 10.1016/j.bbmt.2009.07.004
Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP?EBMT analysis on patients with AML in remission, Bone Marrow Transplantation, vol.18, issue.4, pp.610-611, 2016. ,
DOI : 10.3324/haematol.2013.092254
Chronic graft-versus-host disease, Biology of Blood and Marrow Transplantation, vol.9, issue.4, pp.215-248, 2003. ,
DOI : 10.1053/bbmt.2003.50026
URL : https://hal.archives-ouvertes.fr/hal-00849664
Frailty models for survival data, Lifetime Data Analysis, vol.35, issue.3, pp.255-73, 1995. ,
DOI : 10.1007/BF00985760
Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests, Statistics in Medicine, vol.84, issue.12, pp.1489-500, 1999. ,
DOI : 10.1002/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#
Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Haematologica, vol.102, issue.1, pp.139-188, 2017. ,
DOI : 10.3324/haematol.2016.145631
URL : https://hal.archives-ouvertes.fr/hal-01470403
Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT, Cancer, vol.8, issue.11, 2017. ,
DOI : 10.2217/imt-2015-0023
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study, The Lancet Oncology, vol.16, issue.1, pp.57-66, 2015. ,
DOI : 10.1016/S1470-2045(14)71170-2
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia, New England Journal of Medicine, vol.375, issue.8, pp.740-53, 2016. ,
DOI : 10.1056/NEJMoa1509277
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia, New England Journal of Medicine, vol.371, issue.16, pp.1507-1524, 2014. ,
DOI : 10.1056/NEJMoa1407222
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267531
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial, The Lancet, vol.385, issue.9967, pp.517-545, 2015. ,
DOI : 10.1016/S0140-6736(14)61403-3
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT, Journal of Hematology & Oncology, vol.69, issue.2, p.25, 2016. ,
DOI : 10.1186/s13045-016-0248-3
URL : https://hal.archives-ouvertes.fr/hal-01297485
Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis, Bone Marrow Transplantation, vol.23, issue.12, pp.1599-601, 2016. ,
DOI : 10.1126/scitranslmed.3006960
Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide, Biology of Blood and Marrow Transplantation, vol.20, issue.5, pp.724-733, 2014. ,
DOI : 10.1016/j.bbmt.2014.02.001
URL : http://doi.org/10.1016/j.bbmt.2014.02.001
Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the, Cancer, vol.50, issue.suppl 2, pp.2941-51, 2016. ,
DOI : 10.1002/cncr.30130
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia, Blood, vol.125, issue.16, pp.2486-96, 2015. ,
DOI : 10.1182/blood-2014-09-599894